Aortic Aneurysm Market by Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Product (Catheters, Stent Grafts), Treatment, End-use - Global Forecast 2024-2030

Aortic Aneurysm Market by Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Product (Catheters, Stent Grafts), Treatment, End-use - Global Forecast 2024-2030

The Aortic Aneurysm Market size was estimated at USD 4.43 billion in 2023 and expected to reach USD 4.79 billion in 2024, at a CAGR 8.65% to reach USD 7.92 billion by 2030.

An aortic aneurysm is swelling or bulging in a section of the aorta, the main artery moving blood from the heart to the rest of the body. This condition can occur in any part of the aorta; however, it commonly affects the area in the abdomen (abdominal aortic aneurysm) or the chest (thoracic aortic aneurysm). The growth in the prevalence of aortic aneurysm cases is primarily influenced by factors such as advancing age, smoking, high blood pressure, and genetic predispositions, which weaken the aortic walls. Challenges in managing this condition include the risk of not detecting the aneurysm early since it usually shows no symptoms unless it becomes particularly large or ruptures. Such ruptures can lead to severe complications and even sudden casualties, thereby making timely diagnosis and management critical. However, advancements in diagnostic technologies and surgical techniques present significant opportunities for better management of aortic aneurysms. Improvement in imaging techniques, including computed tomography (CT) and magnetic resonance imaging (MRI), enhances early diagnosis, while innovations in surgical procedures, including minimally invasive surgeries, improve patient outcomes post-diagnosis. Additionally, increasing awareness about the condition and its risk factors among the general population further aids in early detection and preventive care, contributing positively to the overall management of aortic aneurysms.

Regional Insights

Americas demonstrates a significant need for aortic aneurysm treatments and solutions, given its advanced healthcare infrastructure and high prevalence of cardiovascular diseases. Investment in the Americas is robust, emphasizing research and development to innovate new technologies. Recent patents primarily focus on improving surgical tools and non-invasive diagnostic methods. There is also a trend toward personalized treatment plans and increased use of endovascular aneurysm repair (EVAR) procedures. American research often collaborates with international bodies to enhance treatment methodologies and post-operative care. Europe has an established healthcare system that supports extensive research on aortic aneurysms. The EU promotes several cross-country collaborations focusing on innovative treatment technologies, including incorporating Artificial intelligence (AI) for better imaging analysis. The region sees a high rate of healthcare coverage, which aids in the comprehensive management of aortic diseases. The Middle East and Africa region are advancing rapidly, investing in state-of-the-art medical technologies and promoting health tourism. Meanwhile, African areas are gradually increasing efforts through international aid and development programs, although access to advanced care is still limited. Asia-Pacific faces a growing prevalence of aortic aneurysms associated with an aging population and urban lifestyle-related health issues. The country is investing heavily in healthcare reforms and local manufacturing of medical devices. There's a significant advance in community healthcare services to raise awareness and promote early diagnosis. In addition, affordable care initiatives and increased local manufacturing of medical devices are current strategic focuses.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Aortic Aneurysm Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing incidence of aortic aneurysms among aging population
• Rise in awareness campaigns and routine screenings for at-risk populations

Market Restraints

• Rising incidences of product recalls

Market Opportunities

• Advances in medical imaging technology and minimally invasive surgical techniques
• Collaborations between medical institutions

Market Challenges

• Concerns over complications during and after surgery of aortic aneurysms

Market Segmentation Analysis

• Type: Increasing cases of abdominal aortic aneurysm (AAA) found in older individuals with high blood pressure
• End-use: Evolving management and treatment of severe cases of aortic aneurysms in the hospitals

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aortic Aneurysm Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aortic Aneurysm Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

UC Davis Health Initiates Regional First in Clinical Trial Using Innovative, Less Invasive Aortic Device

UC Davis Health's aortic surgery department has embarked on a groundbreaking clinical trial for complex aortic aneurysms, becoming the first in the region to do so. This trial features a novel endovascular aortic device that received a physician-sponsored investigational device exemption (IDE) from the FDA. Distinctively, Maximus is one of only 18 vascular surgeons nationwide and the sole recipient of this exemption in Northern California, allowing him to employ this innovative technology that fixes arteries without requiring invasive surgery.

FDA Approves New Gore Device for Advanced Aortic Aneurysm Treatment, Introducing the Excluder TAMBE Endoprosthesis

Gore & Associates received FDA approval for their new product, the Excluder Thoracoabdominal Branch Endoprosthesis (TAMBE). This device offers a state-of-the-art, minimally invasive solution for treating complex aortic aneurysms, specifically designed for patients facing high surgical risks, such as those with thoracoabdominal and pararenal aortic aneurysms. Utilizing an endovascular approach complemented by advanced imaging techniques, the Excluder TAMBE effectively isolates the aneurysm to maintain uninterrupted blood flow through the aorta. It features a unique design with four precannulated internal portals to support the integration of bridging stent grafts vital for visceral arterial access.

Nectero Medical Launches Pivotal Clinical Trial for Innovative Aortic Aneurysm Treatment

Nectero Medical commenced a significant Phase II/III clinical study, dubbed stAAAble, to evaluate the safety and effectiveness of its Nectero Endovascular Aneurysm Stabilisation Treatment (Nectero EAST) system for patients with infrarenal abdominal aortic aneurysms ranging in size from 3.5 to 5 cm. The innovative Nectero EAST system, which includes a dual-balloon delivery catheter and a stabilizer composed of pentagalloyl glucose (PGG), is designed to locally fortify the aneurysmal wall by enhancing the structural integrity of elastin and collagen within the aorta. This could significantly diminish the risk of further deterioration of the vessel wall.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aortic Aneurysm Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Aortic Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altura Medical Inc., Artivion, Inc., Bentley InnoMed GmbH, Bolton Medical, Inc., Boston Scientific Corporation, Cardinal Health company, Cook Medical Inc., CryoLife, Inc., Endologix Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lemaitre Vascular Inc., LifeTech Scientific Corporation, LivaNova PLC, Lombard Medical, Inc., Medtronic PLC, MicroPort Scientific Corporation, Phenox GmbH, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Aortic Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
• Abdominal Aortic Aneurysm
• Thoracic Aortic Aneurysm
• Product
• Catheters
• Stent Grafts
• Treatment
• Endovascular Aneurysm Repair
• Open Surgical Repair
• End-use
• Ambulatory Surgery Centers
• Clinic
• Hospitals
• Region
• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year